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Tânia Grainha†, Paula Jorge†, Diana Alves, Susana Patrı́cia Lopes
and Maria Olı́via Pereira*
CEB—Centre of Biological Engineering, LIBRO—Laboratory of Research in Biofilms Rosário Oliveira, University of Minho,
Campus de Gualtar, Braga, Portugal
Modern medicine is currently facing huge setbacks concerning infection therapeutics as
microorganisms are consistently knocking down every antimicrobial wall set before them.
The situation becomes more worrying when taking into account that, in both
environmental and disease scenarios, microorganisms present themselves as biofilm
communities that are often polymicrobial. This comprises a competitive advantage, with
interactions between different species altering host responses, antimicrobial effectiveness,
microbial pathogenesis and virulence, usually augmenting the severity of the infection and
contributing for the recalcitrance towards conventional therapy. Pseudomonas
aeruginosa and Candida albicans are two opportunistic pathogens often co-isolated
from infections, mainly from mucosal tissues like the lung. Despite the billions of years of
co-existence, this pair of microorganisms is a great example on how little is known about
cross-kingdom interactions, particularly within the context of coinfections. Given the
described scenario, this study aimed to collect, curate, and analyze all published
experimental information on the molecular basis of P. aeruginosa and C. albicans
interactions in biofilms, in order to shed light into key mechanisms that may affect
infection prognosis, increasing this area of knowledge. Publications were optimally
retrieved from PubMed and Web of Science and classified as to their relevance. Data
was then systematically and manually curated, analyzed, and further reconstructed as
networks. A total of 641 interactions between the two pathogens were annotated,
outputting knowledge on important molecular players affecting key virulence
mechanisms, such as hyphal growth, and related genes and proteins, constituting
potential therapeutic targets for infections related to these bacterial-fungal consortia.
Contrasting interactions were also analyzed, and quorum-sensing inhibition approaches
were highlighted. All annotated data was made publicly available at www.ceb.uminho.pt/
ISCTD, a database already containing similar data for P. aeruginosa and Staphylococcus
aureus communication. This will allow researchers to cut on time and effort when studyinggy | www.frontiersin.org November 2020 | Volume 10 | Article 5505051
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Frontiers in Cellular and Infection Microbiolothis particular subject, facilitating the understanding of the basis of the inter-species and
inter-kingdom interactions and how it can be modulated to help design alternative and
more effective tailored therapies. Finally, data deposition will serve as base for future
dataset integration, whose analysis will hopefully give insights into communications in
more complex and varied biofilm communities.Keywords: Pseudomonas aeruginosa, Candida albicans, biofilms, polymicrobial, coinfection, interactions, databaseINTRODUCTION
In real scenarios, including natural, clinical, and industrial settings,
microorganisms team up to survive the hostile environmental
conditions they are continuously exposed to by building complex
communities called biofilms. Their organization in these surface-
attached microbial communities, embedded in a self-produced
matrix, facilitates the intercellular exchange of metabolites, genetic
material, and signaling molecules (Flemming et al., 2016). Once
established, biofilms are less susceptible to predatory action and
antimicrobial agents compared to their planktonic counterparts
(Flemming andWingender, 2010). In addition to this advantageous
form of microbial life, one type of microorganisms often exists in
close association with other microbial species. Interactions between
different microorganisms may provide an advantage to one party
(antagonism) or both parties (mutualism) (Dhamgaye et al., 2016).
Although most natural biofilms are polymicrobial, most of our
current knowledge about these communities comes from the study
of single-species biofilms, using model bacteria (Coenye and Nelis,
2010; Lebeaux et al., 2013). Recognition of the real impact of
polymicrobial biofilms has triggered a recent interest towards the
study of multi-species communities to learn more about their
behavior (Short et al., 2014).
This is particularly true for the clinical field, since the human
body is well known to be colonized by trillions of microorganisms
pertaining to more than 10,000 different species (Peleg et al., 2010;
Potera, 2014; Bai et al., 2019). Examples of human polymicrobial
diseases include cystic fibrosis (CF) lung infection, otitis media,
biomaterial-associated infections, urinary tract infections,
periodontitis, wound infections, and diabetic ulcers (Short et al.,
2014). The interactions between the microorganisms comprising
polymicrobial communities can exacerbate the severity of
infections, compromising their antimicrobial treatments (Peters
et al., 2012; De Vos et al., 2017). Among the great panoply of
interactions found within the context of human infections,
communication between fungi and bacteria has been the focus
of great interest in the last years (Shirtliff et al., 2009; Diaz et al.,
2014). Candida albicans and Pseudomonas aeruginosa comprise
an example of a clinically relevant fungal-bacterial consortium
commonly found in the respiratory tract and skin (Dhamgaye
et al., 2016).
Pathogenesis of P. aeruginosa
and C. albicans
P. aeruginosa is a motile Gram-negative bacterium ubiquitously
found in nature, including aquatic, terrestrial, animal, plant, and
human environments. It is an opportunistic pathogen with thegy | www.frontiersin.org 2ability to cause life-threatening acute and chronic infections,
especially in hospitalized and immunocompromised individuals,
such as CF lung infection, ventilator associated pneumonia
(VAP), burn wounds, keratitis, otitis media, and urinary tract
and gastrointestinal infections (Moradali et al., 2017; Azam and
Khan, 2019). There are essentially three key factors for P.
aeruginosa pathogenic abilities: production of virulence factors
(VF), resistance to antimicrobial agents, and biofilm formation
(Gellatly and Hancock, 2013).
P. aeruginosa is widely recognized for producing an arsenal of
VF associated to diverse functions, such as motility (e.g. flagella,
pilli), tissue invasion, and damage to the host cells [e.g. proteases
such as elastase, alkaline phosphatase, hemolysins, pyocyanin,
siderophores, endotoxin A, lipopolysaccharide (LPS), exotoxin
A], as well as surface adhesion and biofilm formation (e.g.
alginate, Pel, Psl, lectins) (Hauser, 2011; Strateva and Mitov,
2011; Moradali et al., 2017). In addition to these factors, P.
aeruginosa is known for its remarkable ability to resist
antibiotics. Actually, the World Health Organization (WHO)
has listed carbapenem-resistant P. aeruginosa in the top three
species for which the development of new treatments is in critical
need (WHO, 2017). The major resistance mechanisms of P.
aeruginosa that allow it to withstand the action of antibiotics can
be intrinsic or innate (e.g. restricted outer membrane
permeability, efflux pumps, antibiotic-degrading enzymes),
acquired by either horizontal transfer of resistance genes or by
mutations, or adaptive (e.g. biofilm formation, persister cells)
(Pang et al., 2019). The ability of P. aeruginosa to form biofilms
comprises an advantage in many infections (Mulcahy et al.,
2014). In effect, it is considered the hallmark of chronic
infections and revealing of disease progression. The biofilm
environment triggers the development of small colony variants
and persister cells that can resist higher doses of antibiotics
(Burrows, 2018; Pestrak et al., 2018).
C. albicans is a polymorphic fungus that has the ability to
grow in several different morphological forms, namely yeast,
hyphae, and pseudohyphae, depending on the environmental
conditions (Han et al., 2011). This microorganism is frequently
found as part of the normal microbiota of the skin,
gastrointestinal tract, and female genital tract, being harmless
in the majority of cases (Morales and Hogan, 2010). However, C.
albicans can take advantage of immunocompromised patients
and cause several opportunistic infections (Harriott and Noverr,
2011). Similarly to P. aeruginosa, there are three important
features for the pathogenesis of C. albicans: its ability to switch
from yeast-to-filamentous growth and vice versa, secretion of
VF, and biofilm formation (Poulain, 2015).November 2020 | Volume 10 | Article 550505
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advantages in the development of infection. The filamentous
forms (hyphae and pseudohyphae) are one of its most important
virulence mechanisms (VM), being responsible for host cell
invasion and macrophage destruction, thus having an
important role on the establishment of an infection process
(Vylkova and Lorenz, 2017; Desai, 2018). In turn, the yeast
form is believed to be important for dissemination through the
bloodstream and adhesion to endothelial surfaces (Seman et al.,
2018). This phenotypic switch can be induced by temperature,
pH, nutrient concentration, cell density, and human serum
(Sudbery, 2011). Besides this morphological plasticity, there are
other VF contributing for C. albicans pathogenesis, such as
adhesins (biomolecules that enable binding to the host cells)
and hydrolytic enzymes (e.g. aspartyl proteinases and
phospholipases) (Calderone and Fonzi, 2001; Dadar et al.,
2018). It is now well acknowledged that biofilm formation is
one of the main virulence features involved in the pathogenesis
of C. albicans, as these organized communities confer protection
against antimicrobial therapy and host defenses (Wall
et al., 2019).
Quorum Sensing in P. aeruginosa
and C. albicans
Microorganisms interact by means of a major process that allows
them to coordinately sense and respond to the fluctuating
conditions of the surrounding environment. This cell-to-cell
communication is called quorum-sensing (QS) and small
diffusible signaling molecules, termed autoinducers (AI),
mediate it. AI regulate the expression of target genes, namely
those related to virulence, pathogenicity, resistance, and
competition, when a threshold concentration is reached in
accordance with population density (Fuqua et al., 1994; Dixon
and Hall, 2015; Hawver et al., 2016; Paul et al., 2018). AI-
mediated signaling in QS allows microbial communication and
the control of pivotal processes, namely VF production, biofilm
formation, motility, sporulation, production of secondary
metabolites, and stress adaptation through, for example,
secretion systems (Pena et al., 2019).
The structure and functioning of the QS machineries deployed
by P. aeruginosa have been well elucidated (Jimenez et al., 2012;
Lee and Zhang, 2015; Magalhães et al., 2019). P. aeruginosa
possesses four well-known QS systems: LasI/LasR, RhlI/RhlR,
PqsABCDE/PqsR, and AmbBCDE/IqsR. Each of these systems
produces an AI, namely 3-oxododecanoyl-L-homoserine lactone
(3-oxo-C12-HSL), N-butanoyl homoserine lactone (C4-HSL), 2-
heptyl-3-hydroxy-4-quinolone (Pseudomonas Quinolone
Signal—PQS), and 2-(2-hydroxyphenyl)-thiazole-4-carbaldehyde
(Integrated Quorum Sensing Signal—IQS), respectively
(Magalhães et al., 2019). The hierarchical regulation of P.
aeruginosa QS systems allows triggering massive changes in
genetic expression, namely in genes involved in motility, biofilm
formation, iron sequestration, antibiotic resistance, and immune
system evasion (Shrout et al., 2006; Jakobsen et al., 2013). For
example, the LasI/LasR system controls the production of multiple
VF involved in acute infection and host cell damage, such as LasAFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 3and LasB elastases, exotoxin A, and alkaline protease (Gambello
et al., 1993; Jones et al., 1993; Passador et al., 1993). It also controls
the expression of a major biofilm matrix component, Pel (Ueda
andWood, 2009). In turn, the excretion of bacterial biosurfactants,
such as rhamnolipids, is regulated by the Rhl system (Pearson
et al., 1995), while the PqsABCDE/PqsR system controls biofilm
formation and its structural stability through extracellular DNA
and lectin production (Allesen-Holm et al., 2006; Lee and
Zhang, 2015).
Contrary to the enormous information available about QS in
prokaryotes, QS in the fungal kingdom was somewhat concealed
until the discovery of farnesol, a common sesquiterpene
produced by C. albicans and similar in structure to bacterial 3-
oxo-C12-HSL, in 2001 (Hornby et al., 2001). Although other
molecules mediating QS in C. albicans have been identified since
then, including farnesoic acid (Oh et al., 2001) and aromatic
amino acid derived alcohols like tyrosol (Chen et al., 2004),
tryptophol, and phenylethanol (Lingappa et al., 1969; Chen and
Fink, 2006), farnesol is undoubtedly the most explored AI.
Regulation of fungal virulence by farnesol is thought to be
particularly confined to inhibit yeast-to-hypha transition
(Dižová and Bujdáková , 2017), to promote reverse
morphogenesis (Polke and Jacobsen, 2017), and to inhibit
biofilm development (Khan et al., 2020). Farnesol is known to
directly inhibit the fungal Ras1-cyr1-cAMP-protein kinase A
(PKA) signaling pathway, ultimately blocking cAMP synthesis
and consequently suppressing hyphal development (Davis-Hanna
et al., 2007; Hall et al., 2011; Grahl et al., 2015). Following the same
event cascade, the catalytic subunits of PKA, Tpk1, and Tpk2, are
also stimulated. Tpk1 and Tpk2 share redundant functions in
hyphal growth, adhesion, and biofilm formation, but also have
distinct roles in stress responses and pathogenesis, respectively
(Lindsay et al., 2012; Lin et al., 2018). RAS1, CYR1, and EFG1
(other important hypha-associated genes) have also been
documented as important effector genes targeted by farnesol
(Grainha et al., 2018).
Apart from farnesol, the AI farnesoic acid, tyrosol,
tryptophol, and phenylethanol may also affect important
processes such as morphogenesis, biofilm development,
limitation of cell population density, control of nutrient
competition, and control of infection dissemination (Wongsuk
et al., 2016). Tyrosol, for instance, stimulates C. albicans
filamentation, biofilm formation, and germ tube development
(Chen et al., 2004; Alem et al., 2006), in contrast to farnesol.
Sadly, understanding their underlying regulatory mechanisms is
yet to be fully elucidated.
Interactions Between P. aeruginosa
and C. albicans
Bacteria and fungi often coexist in competitive ecological niches in
a myriad of ways, communicating through excretion of metabolic
by-products, physical interactions, chemical signaling exchanges,
and alterations in the environment (Peleg et al., 2010). P.
aeruginosa and C. albicans are likely the best-studied models in
the investigation of these inter-kingdom interactions in clinical
context, with reports on their impressive interactions andNovember 2020 | Volume 10 | Article 550505
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et al., 2011; Roux et al., 2013; Trejo-Hernández et al., 2014; Kumar
et al., 2017; Rodrigues et al., 2017). Although P. aeruginosa-C.
albicans interplay is fundamentally antagonistic, its interaction is
rather complex, as synergistic and antagonistic effects can occur
simultaneously, mostly dictated by physical associations and by
secreted factors via QS (Fourie et al., 2016; Fourie and Pohl, 2019;
Nogueira et al., 2019).
As stated, P. aeruginosa and C. albicans are frequently co-
isolated in polymicrobial infections, such as those related to the
skin, the lungs, and to medical devices (Méar et al., 2013). Their
genetic and phenotypic plasticity, along with their propensity to
assemble as recalcitrant polymicrobial biofilms, places a
considerable burden in infections in which they are involved,
explaining the increasing interest and the bulk of research on this
topic. For example, it has been well documented that P.
aeruginosa and C. albicans colonize the lungs of CF patients
and readily form biofilms on endotracheal tube surfaces
(Harriott and Noverr, 2011; Fourie et al., 2016). Interestingly,
C. albicans is only implicated in airway colonization in critically
ill (elderly, immunocompromised, and/or hospitalized)
individuals undergoing invasive mechanical ventilation.
However, and despite their antagonistic relationship, those
who display C. albicans tracheobronchial colonization are at
increased risk of acquiring severe VAP infections due to P.
aeruginosa (Hamet et al., 2012).
Effect of P. aeruginosa on C. albicans
The inhibitory effect of P. aeruginosa on C. albicans growth was
first reported in the 1970s (Hughes and Kim, 1973; Auger and
Joly, 1977). In 2002, Hogan and Kolter reported killing of C.Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 4albicans hyphal cells by P. aeruginosa, showing, however, no
such effect on fungal yeasts (Hogan and Kolter, 2002). The
deadly effect imparted by P. aeruginosa was further confirmed
to be largely dependent on the distinct morphotypes exhibited by
C. albicans (Kerr et al., 1999; Hogan and Kolter, 2002; Hogan
et al., 2004). Often, a reversion of germ tube formation may
occur in the presence of P. aeruginosa. The most common event
elucidating the physical interaction among P. aeruginosa and C.
albicans is likely the extensive bacterial attachment to fungal hyphae
(Ovchinnikova et al., 2012; Fourie et al., 2016). Figure 1 displays a
mixed P. aeruginosa-C. albicans 24 h–old biofilm wherein C.
albicans filamentous populations served as a scaffold for P.
aeruginosa attachment (data not published). Physical association
among P. aeruginosa and C. albicans occurs via cell wall-associated
compounds in bacteria, such as type IV pili, lectin-carbohydrate
interactions, and mannans (Brand et al., 2008). The bacterial
attachment to fungal hyphae is hypothesized to be caused by
nutrient competition at the first hour of co-isolation, after which
the bacterial-fungal interaction tends to be of parasitism (Trejo-
Hernández et al., 2014). Secreted LPS, another bacterial cell-wall
component, also functions on polymicrobial intertwining, by
interfering with fungal filamentation, metabolism, and growth
(Bandara et al., 2010; Bandara et al., 2013).
The P. aeruginosa QS signal 3-oxo-C12-HSL plays major
roles in interaction regarding the bacterial binding to
C. albicans filaments and in the inhibition of yeast to hyphae
switch (Hogan et al., 2004; Ovchinnikova et al., 2012). Because
of the inhibition of yeast-to-hypha transformation, C. albicans
gains compromised ability to adhere or invade tissues (Maza
et al., 2017). The 2-heptyl-4-quinolone (HHQ), the immediate
precursor of the PQS signal, has been shown to repressFIGURE 1 | Mixed P. aeruginosa-C. albicans 24 h–old biofilm. Epifluorescence image of a stained biofilm with a mixture of SYTO® BC and propidium iodide (PI)
(Invitrogen™, CA, USA) shows P. aeruginosa PAO1 (PA) cells (highlighted by white arrows) surrounding and colonizing in a great extension the C. albicans SC5314
(CA) hyphae (black arrow). Cells were prepared at approximately 107 CFU/mL in RPMI 1640 media and mixed in equal proportions. Mixed suspensions were
transferred to Thermanox® plastic coverslips, placed in 24-well plates, and incubated at 120 rpm and 37°C for 24 h prior to biofilm analysis.November 2020 | Volume 10 | Article 550505
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the expression of the VF phenazines, such as pyocyanin, which
are toxic products that produce a deleterious effect in
eukaryotic cells (Kaleli et al., 2007; Phelan et al., 2014). This
effect may be associated with the generation of highly toxic
reactive oxygen species (ROS) (O’Malley et al., 2003; Gloyne
et al., 2011). Pyocyanin was shown to reduce cAMP (Kerr
et al., 1999), which is required for yeast-to-hyphae transition
(Gibson et al., 2009; Tupe et al., 2015). The effect of
phenazines, including pyocyanin, in disturbing C. albicans
biofilm formation and hyphal growth has also been
evidenced (Morales et al., 2013; Lindsay et al., 2014). Certain
phenazines have even showed potential to act synergistically in
concert with several azole agents against fungal infection
(Kumar et al., 2014). Along with secreting inhibitory
molecules, P. aeruginosa also produces substances such as
the proteolytic enzyme elastase LasB, which increases the
virulence of C. albicans (Peleg et al., 2010).
Effect of C. albicans on P. aeruginosa
C. albicans secreted factors, such as farnesol, tyrosol, ethanol,
oxylipins, and eicosanoids, have been shown to affect P.
aeruginosa growth and biofilm. C. albicans generally uses
farnesol to resist oxidative stress and to induce the generation
of ROS, thus providing competitive advantage over bacteria
(Westwater et al., 2005). Farnesol has a deleterious effect on P.
aeruginosa, modulating PQS-controlled virulence in a dose-
dependent manner (Cugini et al., 2007). Farnesol is able to
inhibit pyocyanin (Cugini et al., 2007) and rhamnolipid-
mediated swarming motility (McAlester et al., 2008) through
such modulation, while also inhibiting other virulence-related
proteins (Abdel-Rhman et al., 2015).
Tyrosol, another C. albicans AI, has been shown to inhibit
secretion of haemolysin and protease (toxins usually involved in
tissue damage) by P. aeruginosa at high concentrations (Abdel-
Rhman et al., 2015). Ethanol is a common fermentation product
produced by many bacteria and fungi known to influence P.
aeruginosa in diverse polymicrobial settings. In the context of
infections where P. aeruginosa coexists with C. albicans,
exogenous fungal-produced ethanol may alter phenazine
production and promote biofilm development on biotic and
abiotic surfaces. In addition, ethanol enhances bacterial Pel
matrix production and represses surface motility (Lewis et al.,
2019). Its production is continuously stimulated by the enhanced
P. aeruginosa biofilm formation and production of antifungal
phenazines, in a positive feedback loop (Chen et al., 2014).
Eicosanoids (e.g. prostaglandin E2, PGE2) are often secreted by
Candida spp., including C. albicans. Although the role of such
fatty acid metabolites is still to be determined in the bacterial-
fungal cross talk, it has been suggested that they act as
immunomodulatory mediators that affect the dynamics of
mixed bacterial-fungal infections and their outcome (Fourie
et al., 2016; Fourie et al., 2017). Competition for iron is also
one of the main antagonistic interactions occurring in
P. aeruginosa-C. albicans infections. Enhanced secretion of
P. aeruginosa siderophore pyoverdine in mixed species biofilmsFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 5leads to a decrease in iron availability on C. albicans and
consequently to inhibition of yeast growth (Purschke
et al., 2012).
Given the abovementioned information, the purpose of this
study was to gather, curate, and analyze all published
experimental data regarding the molecular basis of P.
aeruginosa and C. albicans interactions, with emphasis on
biofilms. The objective is to provide insights into the key
communication mechanisms and molecular players affecting P.
aeruginosa and C. albicans coexistence, hopefully facilitating the
current understanding of inter-species and inter-kingdom
interplays, and ultimately guide the design for novel and
effective tailored therapies.MATERIALS AND METHODS
Information Retrieval
Medline (PubMed) database (NCBI, 2004) and Web of Science
(Clarivate, 2020) were searched in order to extract information
from the scientific literature related to P. aeruginosa and C.
albicans interactions. The scope of the search was optimized so
that relevant papers were not overlooked but not so broad that
irrelevant papers made the curation effort infeasible. Documents
were narrowed down to those whose title, abstract or MeSH
(Medical Subject Headings) terms mentioned “Pseudomonas
aeruginosa”, “Candida albicans” and, at least, one term related
to interaction (e.g. “co-cultivation”, “mixed biofilms”, “double
species biofilms”, “multispecies”, “polymicrobial”, “consortia”,
“communication”, “quorum-sensing”).
Selection of Studies and Data Extraction
Articles searched on PubMed and Web of Science were classified
as relevant or irrelevant by analyzing each title and abstract for
its suitability for the subject of P. aeruginosa-C. albicans
interactions. When necessary, a full-text article analysis was
performed to confirm its relevance. Irrelevant articles were
deemed as those out of scope, but also reviews, as they would
output duplicated data, and non-English written articles, as they
would not be possible to annotate. Out of scope articles were
those that did not include testing of the two species in
combination or of the effect of exoproducts of one species on
the other. Many articles were deemed irrelevant as specific terms
pertaining to polymicrobial biofilms included in the query (see
Information Retrieval) were only mentioned as part of the
introduction or contextualization.
As for relevant publications, the full-texts were curated and
important information was annotated, namely the interactions
between the two microorganisms and, where possible, the
molecular entities behind such phenomenon. Accessory
information was also annotated, such as strains, mode of
growth, and experimental methods. The entities responsible for
the annotated interactions and the interaction outcomes were
classified into categories, as performed previously (Magalhães
et al., 2019). Briefly, interactions were classified into up- or
downregulation (for gene and protein targets), stimulation orNovember 2020 | Volume 10 | Article 550505
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(for all target entity categories).
Network Reconstruction and Data
Deposition
Data on P. aeruginosa-C. albicans interactions was reconstructed
as networks using Cytoscape (Shannon et al., 2003). Different
node colors and shapes were used to depict distinct source
organisms and entity categories, respectively. All annotated
data was made publicly available in the Inter Species CrossTalk
Database (ISCTD) (www.ceb.uminho.pt/ISCTD) (Magalhães
et al., 2019), which was previously built to deposit data on
communication between microorganisms and was first loaded
with information on the interactions between P. aeruginosa and
Staphylococcus aureus obtained in a similar fashion as the
present work.RESULTS
Exploring the ISCTD
The ISCTD (www.ceb.uminho.pt/ISCTD) (Magalhães et al.,
2019) now provides public access to the annotated information
about P. aeruginosa and C. albicans interactions. Users can
specify search preferences by selecting the direction of the
interaction (P. aeruginosa > C. albicans or C. albicans > P.
aeruginosa) and, optionally, the source and target entity
categories. The respective data selection is shown in a table as
an organized view of all interaction details, such as strains, modes
of growth, experimental methods, and observations made by the
expert curators. Links to PubMed records are always included so
users can easily access the original publications. Users canFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 6further explore and narrow down the selected data by
searching specific terms within the table, such as a specific
mode of growth (e.g. “biofilm”), a VF (e.g. “pyoverdine”), or a
gene (e.g. “lasA”). An example of a search focused on the effect of
P. aeruginosa on C. albicans’ genes in biofilms is illustrated in
Figure 2.
Network Overview
The elaboration of the P. aeruginosa-C. albicans network
comprised the analysis of 164 PubMed and 215 Web of
Science documents (dating from June 1975 to July 2020), of
which 60 were exclusive to the first and 108 to the latter. A total
of 29 documents (dating from December 2004 until May 2020)
(complete reference list in Supplementary Material) were
considered relevant. The annotation of these relevant studies
outputted a total of 641 interactions between the two pathogens,
in which 54% were related to the effect of P. aeruginosa on
C. albicans and 46% to the opposite effect.
The most annotated type of interaction illustrating the effect
of P. aeruginosa on C. albicans was upregulation followed by
downregulation (Figure 3A), which reflects the great number of
proteins and genes that are usually analyzed in studies where
methods such as Matrix-Assisted Laser Desorption/Ionization-
Time Of Flight (MALDI-TOF) and RNA sequencing are used.
These high-throughput studies also explain the great number of
interactions annotated for proteins and genes as targets (Figure
3C). However, this does not translate to a majority of papers
using these techniques. In fact, only 45% of annotated papers
studying the effect of P. aeruginosa on C. albicans analyzed
protein or gene expression, and only 41% used these types of
high-throughput methods. Regarding the source type, the effect
of most interactions was reported for “cell” as the source entityFIGURE 2 | Searching within the ISCTD. (A) Navigation panel that allows users to jump within the webpage, including to the “Search” section. (B) Selection of the
interaction direction of interest, here exemplified by the effect of P. aeruginosa on C. albicans. (C) Selection of the source entity category, which can be left
unspecified by selecting the option “All”. (D) Selection of the target entity category, here exemplified by “gene”. (E) When clicking the “Search” button, a table is
generated containing all the information annotated by the expert curators and sifted through the user’s selection in (B–D). (F) Users can type keywords to further
specify their search, here exemplified by “biofilm”. (G) Table is narrowed down to show only interactions observed in biofilms.November 2020 | Volume 10 | Article 550505
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the interaction was not studied in detail.
As for the effect of C. albicans on P. aeruginosa, the trend is
very similar to the opposite direction. The most annotated
interactions were downregulation and upregulation (Figure
4A), although a preponderance of downregulation is unveiled
here, while the most annotated source and target types were cellFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 7and protein, respectively (Figures 4B, C), by the same reasons
previously mentioned.
Effect of QS Molecular Players on
P. aeruginosa-C. albicans Interactions
Four different AI from P. aeruginosa were annotated for their
effect on C. albicans. For instance, 3-oxo-C12-HSL wasA B
C
FIGURE 3 | Overview of the types of interactions and entities annotated for the effects of P. aeruginosa on C. albicans. (A) Proportional data on the types of
interactions; (B) Total number of interactions annotated for each source category; (C) Total number of interactions annotated for each target category.
AI, autoinducer; VM, virulence mechanism; VF, virulence factor.A B
C
FIGURE 4 | Overview of the types of interactions and entities annotated for the effects of C. albicans on P. aeruginosa. (A) Proportional data on the types of
interactions; (B) Total number of interactions annotated for each source category; (C) Total number of interactions annotated for each target category. Legend: AI,
autoinducer; VM, virulence mechanism; VF, virulence factor.November 2020 | Volume 10 | Article 550505
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et al., 2004; Hall et al., 2011), the secondary messenger cAMP
(Hall et al., 2011), the cAMP synthesis-related enzyme Cyr1
(Hogan et al., 2004), and biofilm formation, while stimulating
C. albicans adhesion to mammalian cells (Curutiu et al., 2017)
(Table 1). As previously mentioned, the morphogenesis of C.
albicans is largely regulated through the cAMP/PKA pathway,
meaning that 3-oxo-C12-HSL is able to inhibit yeast to hyphae
transition by affecting it. Additionally, 3-oxo-C12-HSL was also
shown to downregulate the expression of ECE1, HWP1, and
SAP5, all hyphae-specific genes (Table 1) (Hogan et al., 2004).
As stated, hyphae development by C. albicans is one of its most
important VM, having an important role on the establishment
of the infection process, which is hindered by 3-oxo-C12-HSL.
Although this effect may be apparently detrimental for theFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 8infection, the reversion or maintenance of the fungus in the
yeast form may enhance its dissemination capabilities and
spread the infection to other areas of the host. However, it
has also been shown that the presence of 3-oxo-C12-HSL, at
sub-growth and sub-hyphal inhibitory concentrations,
favorably affects C. albicans when challenged with fluconazole
by upregulation of genes known to be associated with
antimicrobial resistance (e.g. GAL102, MDR2, INO2, ADA2)
(Bandara et al., 2020) (Table 1).
Concerning other AI, C4-HSL, PQS, and its precursor HHQ
were also annotated as interfering with biofilm formation on
inert surfaces but to stimulate C. albicans adhesion to a cellular
substratum (Curutiu et al., 2017) (Table 1). This switch from
antagonistic to synergistic interactions is dependent on the host,
which highlights the need for better understanding the roleTABLE 1 | Effect of AI on P. aeruginosa-C. albicans interactions.






Inhibition Hyphae(p), cAMP(p), Cyr1(p), Biofilm(b) (Hogan et al., 2004; Hall et al., 2011;
Curutiu et al., 2017)
Stimulation Adhesion(b) (Curutiu et al., 2017)
Downregulation ECE1(p), HWP1(p), SAP5(p), CDR1(b), MDR1(b), C6_02100W_A(b), CRH11(b), FBA1(b),
IFR2(b), MNN12(b), PHHB(b), SOD5(b), TEL1(b)
(Hogan et al., 2004; Hall et al., 2011;
Bandara et al., 2020)
Upregulation CDR2(b), AAF1(b), ADA2(b), ADH3(b), ALK2(b), ALS7(b), ARD(b), ATX1(b), AXL1(b),
BCR1(b), C1_01130W_A(b), C1_01510W_A(b), C1_03990W_A(b), C1_04010C_A(b),
C1_09210C_A(b), C2_01750C_A(b), C2_02920W_A(b), C2_03690C_A(b),
C2_09880C_A(b), C3_00360W_A(b), C3_02630C_A(b), C3_03460C_A(b),
C3_04330C_A(b), C3_05450C_A(b), C4_02740W_A(b), C4_03020W_A(b),
C5_04030W_A(b), C6_00110C_A(b), C6_00290W_A(b), C6_00920W_A(b),
C7_00770W_A(b), C7_04090C_A(b), CDR4(b), CR_00040C_A(b), CR_05860W_A(b),
CR_06140W_A(b), CR_06960W_A(b), CR_07480W_A(b), CR_09100C_A(b),
CR_10230W_A(b), CRZ2(b), CSH1(b), CUP9(b), EFG1(b), ERO1(b), GAL102(b),
GOR1(b), GRP2(b), HAL9(b), HSP104(b), HSP78(b), HSP90(b), IFD6(b), INO2(b), ISA1(b),
LPG20(b), MHP1(b), MOH1(b), NRG1(b), OPT3(b), PGA52(b), RFG1(b), RGS2(b),
RME1(b), RPN4(b), SIS1(b), SNQ2(b), SRR1(b), STI1(b), UGT51C1(b), WOR4(b), YIM1(b),
YOR1(b), ZCF1(b), ZCF39(b)
(Bandara et al., 2020)
C4-HSL Inhibition Biofilm(b) (Curutiu et al., 2017)
Stimulation Adhesion(b)
HHQ Inhibition Biofilm(b) (Reen et al., 2011; Curutiu et al., 2017)
Stimulation Adhesion(b) (Curutiu et al., 2017)
Null effect Hyphae(p), Adhesion(b) (Reen et al., 2011)
PQS Inhibition Biofilm(b) (Curutiu et al., 2017)
Stimulation Adhesion(b)
Null effect Hyphae(p) (Reen et al., 2011; Watrous et al., 2013)
C.
albicans
Farnesol Inhibition PQS(p), Adhesion(b), Swarming motility(p), Pyocyanin(p), Haemolysin(p), Cell(p) (Cugini et al., 2007; McAlester et al.,
2008; Abdel-Rhman et al., 2015)
Downregulation pqsA(p), pqsR(p) (Cugini et al., 2007)
Null effect Cell(p);(v), pqsR(p), Proteases(p) (Cugini et al., 2007; Abdel-Rhman et al.,
2015; Lopez-Medina et al., 2015)
Upregulation pqsH(b) (Cugini et al., 2010)
Stimulation HHQ(b), PQS(b), C4-HSL(b), Pyocyanin(b)
Tyrosol Inhibition Haemolysin(p), Proteases(p), Cell(p) (Abdel-Rhman et al., 2015)Novep, planktonic; b, biofilm; v, in vivo.mber 2020 | Volume 10 | Article 550505
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have multifunctional roles in QS and iron uptake, playing a key
role in coordinating virulence in P. aeruginosa (Diggle et al.,
2007). Although the annotated effect of these molecules on C.
albicans hyphae was null (Reen et al., 2011; Watrous et al., 2013),
HHQthey seems to interfere with biofilm formation (Table 1)
(Reen et al., 2011; Curutiu et al., 2017). Overall, there is a clear
negative effect on the phenotypic switching and biofilm
formation of C. albicans mediated through QS of P. aeruginosa
when the host is not considered.
Regarding the two annotated AI of C. albicans, farnesol, and
tyrosol, the former seems to affect the production of AI from P.
aeruginosa, namely PQS (Cugini et al., 2007; Cugini et al., 2010),
HHQ, and C4-HSL (Cugini et al., 2010) (Table 1). Farnesol is
also involved in the inhibition of different VM and VF of this
bacterium, such as adhesion, swarming motility, and haemolysin
production (Cugini et al., 2007; McAlester et al., 2008; Abdel-
Rhman et al., 2015) (Table 1). Distinct farnesol effects were also
observed between planktonic and biofilm growth for pyocyanin
production (Table 1). Tyrosol was also annotated as affecting
the production of VF of P. aeruginosa, namely the inhibition of
the production of haemolysin and proteases (Abdel-Rhman
et al., 2015) (Table 1). These two exoenzymes greatly influence
the pathogenicity of P. aeruginosa, contributing to infection
establishment through elastin degradation and vascular
permeability, respectively (Azam and Khan, 2019).
Overall, it is safe to say that QS in both pathogens is a key factor
mediating their antagonistic relationship, with their capacity for
infection establishment being one of their most affected traits.
Interaction Effects on Virulence
Mechanisms and Virulence Factors
The influence of inter-species interactions on the expression of
VM and VF can greatly affect the severity of the polymicrobial
infection. Given their importance, two networks were constructedFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 9regarding the effects of one species on the virulence of the other.
Concerning the effect of P. aeruginosa on C. albicans, hyphal
development was the most annotated VM (Figure 5), for which
the majority of interactions (75%) were inhibitory. Concerning the
most reported source entities affecting hyphae, most annotated
interactions reported effects of bacteria as a whole (annotated as
“cell”), meaning that no molecular entity was identified/tested.
LPS, rhamnolipids, and 3-oxo-C12-HSL were also annotated as
inhibiting hyphal growth (Hall et al., 2011; Bandara et al., 2013;
Watrous et al., 2013), while HHQ and PQS had no effect (Reen
et al., 2011; Watrous et al., 2013). Biofilm formation by C. albicans
was the second most annotated affected VM as result of P.
aeruginosa interaction. In this case, almost all interactions were
inhibitory (93%) and caused by different source entities (Figure 5).
No VF were annotated for C. albicans.
Regarding the effect of C. albicans on P. aeruginosa, swarming
motility, adhesion, and biofilm formation were the most
annotated VM (Figure 5). Swarming motility is inhibited in
the presence of C. albicans due to farnesol (McAlester et al.,
2008) and ethanol (Chen et al., 2014). The adhesion capability of
P. aeruginosa was annotated as inhibited by farnesol (McAlester
et al., 2008) and stimulated by ethanol (Chen et al., 2014). In the
case of biofilm formation, 50% of interactions were of
stimulation and the other 50% had a null effect. Concerning
the source entities, these distinct biofilm effects were both
annotated for the entity “cell”, while only stimulation was
annotated for ethanol (Figure 5).
Pyocyanin production by P. aeruginosa was the most
annotated VF (Figure 5) and the effect of C. albicans on this
molecule apparently depends on the mode of growth, with
stimulation in biofilm growth and inhibition in planktonic
growth. These differences are further explored in a later
section. Other annotated VF includes pyoverdine, proteases,
rhamnolipids, and haemolysin (Figure 5). All interactions
annotated for pyoverdine and rhamnolipids were stimulatory,FIGURE 5 | Network of the effects of P. aeruginosa-C. albicans interactions on VF and VM. Teal nodes, P. aeruginosa; orange nodes, C. albicans; green arrows,
stimulation; grey arrows, null effect; red arrows: inhibition; node and node label sizes are directly proportional to the number of related (outward and inward) edges
(interactions).November 2020 | Volume 10 | Article 550505
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for the first and both planktonic and biofilm as modes of growth
for the latter. Both AI of C. albicans, farnesol and tyrosol, were
annotated as inhibiting haemolysin in P. aeruginosa in
planktonic cultures (Abdel-Rhman et al., 2015). Regarding the
production of proteases, tyrosol inhibited these enzymes, while a
null effect was annotated for farnesol, in the planktonic mode of
growth (Abdel-Rhman et al., 2015).
Interaction Effects on Gene and Protein
Expression
Concerning the expression of genes and proteins as result of
microbial interaction, it was possible to annotate a total of 110
distinct genes differentially expressed in C. albicans due to the
presence of P. aeruginosa, of which 83 were upregulated, 21 were
downregulated, and six were both up and downregulated (Figure
6). These findings are correlated with the affected VM previously
mentioned, especially hyphal growth. For instance, HWP1 and
ECE1, along with ALS3, all hyphae-specific genes, were
downregulated in the presence of 3-oxo-C12-HSL (Hogan
et al., 2004) and of P. aeruginosa “cell” (Park et al., 2014) and
its supernatant (Holcombe et al., 2010). These results are in
accordance with the well-known inhibitory effect annotated for
hyphal growth. However, there are some cases where some
contradictory effects were annotated for other source entities,
namely LPS upregulation of the previously mentioned genes
(Bandara et al., 2013). This and other contrasting annotations are
discussed in the next section.
With concern to protein expression, C. albicans differentially
expressed 117 proteins, of which 59 were annotated asFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 10upregulated and 69 as downregulated (Figure 7). Some
proteins are reported in more than one paper or even with
different interaction types in the same paper; hence, there is a
greater number of annotated interactions (Figure 7) in relation
to the total number of different annotated proteins. Almost all
interactions with proteins had “cell” as the source entity. Protein
expression was also shown to vary depending on the time of
maturation of the dual-species biofilm. For instance, proteins
related with adhesion and biofilm formation, namely Als1, Als2,
Als3, and Pbr1, seem to be negatively affected by the presence of
P. aeruginosa in a time dependent manner, being less expressed
in later stages of biofilm development. The differences observed
throughout time can be related with the interaction between both
pathogens that probably is more pronounced with increased time
of interaction, correlating with the lowering of the metabolic
activity of C. albicans in the double consortia (Purschke
et al., 2012).
Three different proteins related to virulence in C. albicans,
namely Tfp1, Ape2, and Bgl2, were annotated as upregulated in
the presence of P. aeruginosa (Trejo-Hernández et al., 2014).
This upregulation could have a synergistic interaction with the
VF of the bacterium, resulting in enhanced pathogenesis. All
proteins of the cell wall were annotated as downregulated after
interaction of the fungus with P. aeruginosa. This includes the
cell wall proteins Crh11 and Ecm33, involved in cell wall
assembly and regeneration, filamentation, and adherence to
host cells, and also the hyphal cell wall proteins Rbt5, Hyr1,
Ece1, and Rbe1 (Purschke et al., 2012).
Regarding the effect of C. albicans on the gene expression of P.
aeruginosa, 19 differentially expressed genes were annotated, ofFIGURE 6 | Network of the effects of P. aeruginosa on C. albicans gene expression. Legend: Teal nodes, P. aeruginosa; orange nodes, C. albicans; green arrows,
upregulation; grey arrows, null effect; red arrows: downregulation; node and node label sizes are directly proportional to the number of related (outward and inward)
edges (interactions).November 2020 | Volume 10 | Article 550505
Grainha et al. Pseudomonas aeruginosa and Candida albicans InteractionsFIGURE 7 | Network of the effects of P. aeruginosa on C. albicans protein expression. Legend: Teal nodes, P. aeruginosa; orange nodes, C. albicans; green
arrows, upregulation; grey arrows, null effect; red arrows: downregulation; node and node label sizes are directly proportional to the number of related (outward and
inward) edges (interactions).FIGURE 8 | Network of the effects of C. albicans on P. aeruginosa gene expression. Legend: Teal nodes, P. aeruginosa; orange nodes, C. albicans; green arrows,
upregulation; grey arrows, null effect; red arrows: downregulation; node and node label sizes are directly proportional to the number of related (outward and inward)
edges (interactions).Frontiers in Cellular and Infection Microbiology | www.frontiersin.org November 2020 | Volume 10 | Article 55050511
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8). It was very interesting to note that almost all interactions were
of downregulation (90%). In fact, pqsH was the only gene of P.
aeruginosa annotated as being upregulated in the presence of
farnesol (Cugini et al., 2007). This QS-related gene is involved
in the terminal step of the biosynthesis of quinolones by
catalyzing the hydroxylation of HHQ to PQS (Déziel et al.,
2004). Most of the downregulated annotated genes belong to
the pvd and pch gene families (Figure 8) in planktonic and in
vivo conditions. Interestingly, the related protein PchD was
upregulated in biofilm conditions (Purschke et al., 2012; Trejo-
Hernández et al., 2014). These and other contrasting annotations
are discussed in the next section.
Concerning the expression of proteins, P. aeruginosa
differentially expressed 147 proteins due to the presence of C.
albicans. A total of 92 of these proteins were upregulated and 86
were downregulated (Figure 9). The majority of the annotated
proteins from P. aeruginosa related to virulence were upregulated
due to the interaction with C. albicans. For instance, proteins
related to siderophore biosynthesis and/or transport, namely
ChtA, FptA, FpvA, PchD, FpvB, PvdA, PvdH, PvdF, and PvdQ,
were all upregulated in biofilm settings (Purschke et al., 2012;
Trejo-Hernández et al., 2014). Other upregulated proteins,
namely OpdO, OpdP OpmH, Opr86, OprC, OprE, and OprQ,
are involved in the transport of small molecules and antibioticFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 12resistance (Trejo-Hernández et al., 2014). HasA and HasR, two
proteins related to heme uptake, were also upregulated as well as
PilQ and XcpQ, which are proteins responsible for motility and
attachment of the bacterium (Purschke et al., 2012; Trejo-
Hernández et al., 2014). Proteins involved in cell wall and LPS
synthesis, namely, GlmU, RmlA, and WbpA, were also annotated
as upregulated. These findings reinforce the notion that P.
aeruginosa becomes more virulent as consequence of the
interaction with C. albicans.
Contrasting Annotations Illustrating the
Complexity of Interspecies Study
Upon the analysis of all the gathered information, it was possible
to discern some seemingly opposite effects annotated from the
literature regarding P. aeruginosa-C. albicans interactions. All of
these annotated interactions are outlined in Tables 2 and 3 for
P. aeruginosa > C. albicans and C. albicans > P. aeruginosa
interactions, respectively. These tables contain not only
information on the interactions but also on the experimental
conditions in which they were observed, as these define
their comparability.
One of the more noticeable factors leading to contrasting
observations is the period of time during which cells are co-
cultivated or exposed to each other’s molecular factors (e.g. AI,
supernatants). For example, Purschke and colleagues showedFIGURE 9 | Network of the effects of C. albicans on P. aeruginosa protein expression. Legend: Teal nodes, P. aeruginosa; orange nodes, C. albicans; green
arrows, upregulation; grey arrows, null effect; red arrows: downregulation; node and node label sizes are directly proportional to the number of related (outward and
inward) edges (interactions).November 2020 | Volume 10 | Article 550505
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Target Interaction Source Mode of
growth
Experimental Conditions* Method Strains Reference
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Target Interaction Source Mode of
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Experimental Conditions* Method Strains Reference
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Grainha et al. Pseudomonas aeruginosa and Candida albicans Interactionsthe time-dependent differential expression of several P.
aeruginosa and C. albicans proteins when the two
microorganisms are grown together as mixed biofilms
(Purschke et al., 2012). Many of these proteins are up- or
downregulated dependent if cells are harvested at early or late
time points (or vice-versa), which is corroborated by some
similar observations in other publications (Tables 2, 3).
However, this is not always the case. For instance, Als3, a
hyphae specific protein of C. albicans , appears to be
upregulated at early and downregulated at later time-points
when in contact with P. aeruginosa or its supernatant
(Holcombe et al., 2010; Purschke et al., 2012; Park et al.,
2014). Still, ALS3 was shown to be upregulated by LPS at
48 h (Bandara et al., 2013) (Table 2). The effect of LPS isFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 15concentration and strain dependent (Bandara et al., 2013),
which could explain the differences observed.
Another important factor is the effector entity at play.
Although most papers, as previously mentioned, use the whole
bacterial cell to investigate its effect onto the other co-existing
species, many studies use single molecular players to try to
pinpoint the exact mechanisms behind the observed
interactions. However, even when one molecular player seems
to correlate with the effect of the whole cell, others sometimes
seem to contradict it. For example, the gene CDR1 encodes a
drug efflux pump protein that is upregulated by the supernatant
of P. aeruginosa PAO1 (Holcombe et al., 2010) but
downregulated by 3-oxo-C12-HSL in C. albicans biofilms
(Bandara et al., 2020) (Table 2). Although 3-oxo-C12-HSL isTABLE 2 | Continued
Target Interaction Source Mode of
growth
Experimental Conditions* Method Strains Reference
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(n.a.) (Cugini et al.,
2010)
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Welch, 2019)
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Grainha et al. Pseudomonas aeruginosa and Candida albicans Interactionsextracellular, therefore usually present in P. aeruginosa’s
supernatants, this contrasting observation is likely due to other
metabolites present in the supernatant perceived as detrimental
by Candida, which, therefore, activates efflux pumps to extrude
them (Holcombe et al., 2010).
The type of media and, as consequence, the mode of growth
are also key factors to take into consideration when analyzing
interspecies studies. Cugini et al demonstrated that farnesolFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 19inhibits PQS in a liquid P. aeruginosa culture (Cugini et al.,
2007), but stimulates PQS production when P. aeruginosa is
grown in solid media (Cugini et al., 2010). Virulence related
genes, namely fptA, fpvA, pchD, pvdF, and pvdH were upregulated
in P. aeruginosa biofilms (Purschke et al., 2012; Trejo-Hernández
et al., 2014) but downregulated in planktonic cultures and in an
in vivo murine model of a gastro-intestinal (GI) infection
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Grainha et al. Pseudomonas aeruginosa and Candida albicans InteractionsP. aeruginosa is present in two populations: i) in the gut lumen
and ii) adherent to the epithelium, in which only a subset may be
in biofilms (Lopez-Medina et al., 2015).
It is safe to say that the comparability of the observations
made in interspecies studies is highly, if not totally, dependent on
the experimental conditions, which should mimic, as far as
possible, the real-l ike conditions of infections. The
standardization of experiments and methodologies should be a
priority in order to more quickly advance this research area.
Alternative Approaches in P. aeruginosa-
C. albicans Biofilm Control: QS Inhibition
Biofilm is known as the preferred mode of growth of most
microorganisms, including bacterial and fungal pathogens.
These consortia are typically resilient with dynamic structures,
giving their microbial constituents a broad range of advantages,
as previously mentioned. In real infection scenarios,
microorganisms are usually found in the biofilm form and
these consortia can easily turn an infection into a chronic
condition (Bjarnsholt, 2013). Thus, although planktonic testing
is practical and informative, studies involving biofilms can better
mimic a real-life infection scenario and allow a better
comprehension about the microbial behavior under these
situations. Concerning the annotated information in this work,
although the number of annotated interactions was higher for
biofilms (83%), this only reflects the types of methods being used.
Actually, the number of studies using planktonic or biofilm as
the mode of growth was similar (1518 vs 1417, respectively),
which shows that biofilm studies are still lacking in order to get a
real perspective on these inter-species interactions.
Given the biofilm problematic, along with the ever-rising
antimicrobial resistance, the need for alternative therapies is in
high demand. For example, antivirulence agents carry
advantages like circumvention of antibiotic resistance, by
targeting VF rather than bacterial growth (Totsika, 2016),
and a high number of putative virulent targets (Allen et al.,
2014). Considering that QS is the main regulator of virulence in
both bacteria and fungi, the use of quorum quenching (QQ)
compounds that inhibit specific QS mechanisms related to
virulence can be a promising strategy to modulate it (Chan
et al., 2015). Additionally, QQ compounds are probably less
likely to induce resistance in cases where their targets are
located extracellularly (Fetzner, 2015). Notwithstanding all
the advantages, target selection in this approach is of critical
importance given the existence of redundancy and alternative
regulatory pathways, which may compensate for a given
disturbance, and the complexity of the outcomes of inter-
species interactions, which can make an apparently
detrimental effect on the pathogen lead to an opposite desired
effect in the infection as a whole. For example, the interference
with the QS system of one pathogen can potentially facilitate
the pathogenicity of the other co-infecting species. Moreover,
effective anti-virulence therapy would probably entail
combinations with other agents, such as other antivirulence
drugs or even antibiotics, to increase antimicrobial effectiveness
in polymicrobial communities (Magalhães et al., 2019). OtherFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 20factors to take into account when designing anti-QS approaches
is the negative impacts on the host and its microflora, the
possibility of bacteremia/sepsis as a consequence of the biofilm
disruption, altered immune and inflammatory responses, and
resistance development for intracellular targets (Krzyżek, 2019)
As far as it was possible to check, there are no studies
regarding the use of anti-QS or anti-virulence compounds
against polymicrobial biofilms of P. aeruginosa and C. albicans.
However, some interesting works have been published recently
for each pathogen alone. Works prior to 2017 for P. aeruginosa
and to 2018 for C. albicans can be consulted in the publications
by Pérez-Pérez et al. (2017) and Grainha et al. (2018),
respectively. Particularly, some focus has been given to anti-QS
agents targeting the major regulator PqsR. This QS system of P.
aeruginosa, related to the AI PQS and to HHQ, plays a major role
in biofilm formation and inflammation, being crucial in chronic
infection establishment. Such agents include synthetic
compounds, such as quinolone- and quinazolinone-based
derivatives, that compete and/or antagonize this QS system,
but also natural compounds (Soheili et al., 2019). Concerning
their impact on co-infection scenarios, not much information
was annotated for the effect of this system and its AI on C.
albicans. HHQ was annotated as inhibiting C. albicans biofilm
formation in a concentration dependent-manner (Reen et al.,
2011), which means that disruption of HHQ action could be
detrimental for P. aeruginosa but positive for the fungus.
The idea of using the AI themselves to control virulence and
biofilm formation has also been tested. There are many studies
using exogenous farnesol to control biofilms of C. albicans
(Grainha et al., 2018). A recent study used both farnesol and
tyrosol to control C. albicans biofilms in hopes of using them as
adjuvant in oral hygiene (Sebaa et al., 2019). In fact, farnesol was
annotated as affecting the production of AI from P. aeruginosa,
namely PQS, HHQ, and C4-HSL, and their related genes,
depending on the mode of growth. The upregulation of the
expression of AI and of the VF pyocyanin by farnesol in P.
aeruginosa in biofilm settings (Cugini et al., 2010) has to be
evaluated concerning the effect of this molecule if used to treat
mixed consortia.CONCLUSIONS
It is well known that P. aeruginosa and C. albicans coexist in many
infections, but, unfortunately, the mechanisms of bacterial-fungal
interactions remain unclear. A better understanding of the social
behavior in the consortium and how microbes change their
virulence as result of established interactions is clinically
relevant, being crucial to comprehend the infection process
while simultaneously guiding new effective therapeutic strategies.
Bacteria and fungi influence each other directly or indirectly in
different ways and this work clearly illustrated the amount and
complexity of the mechanisms behind such interactions.
Importantly, it was interesting to observe that the interaction
type was dependent on experimental conditions, namely the
mode of growth.November 2020 | Volume 10 | Article 550505
Grainha et al. Pseudomonas aeruginosa and Candida albicans InteractionsThis work allowed the deposition of all available
information on the scientific literature regarding P.
aeruginosa and C. albicans interactions on an existing
database (www.ceb.uminho.pt/ISCTD) which will assist
research on this topic by cutting on effort and time spent
tracking down and analyzing the scientific literature. As
future work, a continuous update of this knowledge database
will be performed, with additional information of new
discoveries and new microorganisms.DATA AVAILABILITY STATEMENT
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Déziel, E., Lépine, F., Milot, S., He, J., Mindrinos, M. N., Tompkins, R. G., et al.
(2004). Analysis of Pseudomonas aeruginosa 4-hydroxy-2-alkylquinolines
(HAQs) reveals a role for 4-hydroxy-2-heptylquinoline in cell-to-cell
communication. Proc. Natl. Acad. Sci. U.S.A. 101, 1339–1344. doi: 10.1073/
pnas.0307694100
Dhamgaye, S., Qu, Y., and Peleg, A. Y. (2016). Polymicrobial infections involving
clinically relevant Gram-negative bacteria and fungi. Cell. Microbiol. 18, 1716–
1722. doi: 10.1111/cmi.12674
Diaz, P.II, Strausbaugh, L. D., and Dongari-Bagtzoglou, A. (2014). Fungal-
bacterial interactions and their relevance to oral health: Linking the clinic
and the bench. Front. Cell. Infect. Microbiol. 4, 101. doi: 10.3389/
fcimb.2014.00101
Diggle, S. P., Matthijs, S., Wright, V. J., Fletcher, M. P., Chhabra, S. R., Lamont,
I. L., et al. (2007). The Pseudomonas aeruginosa 4-quinolone signal molecules
HHQ and PQS play multifunctional roles in quorum sensing and iron
entrapment. Chem. Biol. 14, 87–96. doi: 10.1016/j.chembiol.2006.11.014
Dixon, E. F., and Hall, R. A. (2015). Noisy neighbourhoods: quorum sensing in
fungal-polymicrobial infections. Cell. Microbiol. 17, 1431–1441. doi: 10.1111/
cmi.12490
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Méar, J.-B., Kipnis, E., Faure, E., Dessein, R., Schurtz, G., Faure, K., et al. (2013).
Candida albicans and Pseudomonas aeruginosa interactions: more than an
opportunistic criminal association? Méd. Mal. Infect. 43, 146–151.
doi: 10.1016/j.medmal.2013.02.005
Moradali, M. F., Ghods, S., and Rehm, B. H. A. (2017). Pseudomonas aeruginosa
lifestyle: A paradigm for adaptation, survival, and persistence. Front. Cell.
Infect. Microbiol. 7, 39. doi: 10.3389/fcimb.2017.00039
Morales, D. K., and Hogan, D. A. (2010). Candida albicans interactions with
bacteria in the context of human health and disease. PloS Pathog. 6, e1000886.
doi: 10.1371/journal.ppat.1000886
Morales, D. K., Grahl, N., Okegbe, C., Dietrich, L. E. P., Jacobs, N. J., and Hogan,
D. A. (2013). Control of Candida albicans metabolism and biofilm formation
by Pseudomonas aeruginosa phenazines. MBio 4, e00526–12. doi: 10.1128/
mBio.00526-12Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 23Mulcahy, L. R., Isabella, V. M., and Lewis, K. (2014). Pseudomonas aeruginosa
Biofilms in Disease. Microb. Ecol 18, 1–12. doi: 10.1007/s00248-013-0297-x
NCBI (2004). PubMed [Internet]. Bethesda Natl. Libr. Med. (US), Natl. Cent.
Biotechnol. Inf. Available at: https://pubmed.ncbi.nlm.nih.gov/ (Accessed
February 14, 2020).
Nogueira, F., Sharghi, S., Kuchler, K., and Lion, T. (2019). Pathogenetic impact of
bacterial–fungal interactions. Microorganisms 7, 459. doi: 10.3390/
microorganisms7100459
Oh, K.-B., Miyazawa, H., Naito, T., and Matsuoka, H. (2001). Purification and
characterization of an autoregulatory substance capable of regulating the
morphological transition in Candida albicans. Proc. Natl. Acad. Sci. 98,
4664–4668. doi: 10.1073/pnas.071404698
O’Brien, T. J., and Welch, M. (2019). A Continuous-Flow Model for in vitro
Cultivation of Mixed Microbial Populations Associated With Cystic Fibrosis
Airway Infections. Front. Microbiol. 10, 2713. doi: 10.3389/fmicb.2019.02713
O’Malley, Y. Q., Abdalla, M. Y., McCormick, M. L., Reszka, K. J., Denning, G. M.,
and Britigan, B. E. (2003). Subcellular localization of Pseudomonas pyocyanin
cytotoxicity in human lung epithelial cells. Am. J. Physiol. - Lung Cell. Mol.
Physiol. 284, L420–L430. doi: 10.1152/ajplung.00316.2002
Ovchinnikova, E. S., Krom, B. P., Van Der Mei, H. C., and Busscher, H. J. (2012).
Force microscopic and thermodynamic analysis of the adhesion between
Pseudomonas aeruginosa and Candida albicans. Soft Matter 8, 6454–6461.
doi: 10.1039/c2sm25100k
Pang, Z., Raudonis, R., Glick, B. R., Lin, T. J., and Cheng, Z. (2019). Antibiotic
resistance in Pseudomonas aeruginosa: Mechanisms and alternative
therapeutic strategies. Biotechnol. Adv. 37, 177–192. doi: 10.1016/
j.biotechadv.2018.11.013
Park, S. J., Han, K. H., Park, J. Y., Choi, S. J., and Lee, K. H. (2014). Influence of
bacterial presence on biofilm formation of Candida albicans. Yonsei Med. J. 55,
449–458. doi: 10.3349/ymj.2014.55.2.449
Passador, L., Cook, J. M., Gambello, M. J., Rust, L., and Iglewski, B. H. (1993).
Expression of Pseudomonas aeruginosa virulence genes requires cell-to-cell
communication. Science 260, 1127–1130. doi: 10.1126/science.8493556
Paul, D., Gopal, J., Kumar, M., and Manikandan, M. (2018). Nature to the natural
rescue: Silencing microbial chats. Chem. Biol. Interact. 280, 86–98.
doi: 10.1016/j.cbi.2017.12.018
Pearson, J. P., Passador, L., Iglewski, B. H., and Greenberg, E. P. (1995). A second
N-acylhomoserine lactone signal produced by Pseudomonas aeruginosa. Proc.
Natl. Acad. Sci. U. S. A. 92, 1490–1494. doi: 10.1073/PNAS.92.5.1490
Peleg, A. Y., Hogan, D. A., and Mylonakis, E. (2010). Medically important
bacterialg-fungal interactions. Nat. Rev. Microbiol. 8, 340–349. doi: 10.1038/
nrmicro2313
Pena, R. T., Blasco, L., Ambroa, A., González-Pedrajo, B., Fernández-Garcıá, L.,
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